Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019 | Zendy

Yijia Li | Zendy; Linda J Harrison | Zendy; Kara W. Chew | Zendy; Judy Currier | Zendy; David A. Wohl | Zendy; Eric S. Daar | Zendy; Teresa H. Evering | Zendy; Ryan Wu | Zendy; Mark J Giganti | Zendy; Justin Ritz | Zendy; Arzhang Cyrus Javan | Zendy; Robert W. Coombs | Zendy; Carlee Moser | Zendy; Michael D. Hughes | Zendy; Joseph J. Eron | Zendy; Davey M. Smith | Zendy; Jonathan Z. Li | Zendy

Open Access

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019

Author(s) -

Yijia Li,

Linda J Harrison,

Kara W. Chew,

Judy Currier,

David A. Wohl,

Eric S. Daar,

Teresa H. Evering,

Ryan Wu,

Mark J Giganti,

Justin Ritz,

Arzhang Cyrus Javan,

Robert W. Coombs,

Carlee Moser,

Michael D. Hughes,

Joseph J. Eron,

Davey M. Smith,

Jonathan Z. Li

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac818

Subject(s) - medicine , placebo , coronavirus , covid-19 , clinical trial , respiratory disease , respiratory system , disease , betacoronavirus , immunology , pathology , infectious disease (medical specialty) , lung , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research